Trial record 1 of 1 for:    CALAA-01
Previous Study | Return to List | Next Study

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Calando Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00689065
First received: May 29, 2008
Last updated: October 30, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Publications: